Edition:
United States

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.31USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,249
52-wk High
$2.65
52-wk Low
$0.69

Chart for

About

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II... (more)

Overall

Beta: -0.83
Market Cap(Mil.): $30.59
Shares Outstanding(Mil.): 23.35
Dividend: --
Yield (%): --

Financials

  VTGN.OQ Industry Sector
P/E (TTM): -- 28.29 30.45
EPS (TTM): -1.17 -- --
ROI: -416.96 12.92 12.63
ROE: -1,346.50 14.94 14.82

Competitors

Earnings vs. Estimates